EUVIMEDEUVIMED entdecken
Open Access

Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Marissa LoCastro iD, Andrea Baran iD, Jane Liesveld iD, Eric Huselton, Elaine Hill iD, Kah Poh Loh iD, Jason H Mendler iD

JCO Oncology Practice · 2025

DOI: 10.1200/op-24-00556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Marissa LoCastro und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Dentistry, University of Rochester, Rochester, NY. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Terminal Care, Hospitalization. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE We previously demonstrated that early completion of portable medical orders, known as Medical Orders for Life-Sustaining Treatment (MOLST), was associated with lower-intensity care at the end of life (EOL) for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The purpose of this study was to investigate the impact of a MOLST form completed before hospitalization on the cost of inpatient care during the last 30 days of life for patients with AML and MDS. METHODS We conducted a retrospective study of 271 adult patients with a diagnosis of AML or MDS who died between January 1, 2014, and December 31, 2019, and received care for their hematologic malignancy at the University of Rochester Medical Center (URMC). Costs were hospital charges for inpatient care at URMC. Nonparametric Wilcoxon rank-sum tests were used to compare costs between diagnosis and age subgroups (AML v MDS, ≥60 years old v

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteTerminal CareHospitalizationHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAged, 80 and overAdultInpatients

Autor:innen und Institutionen

  • School of Medicine and Dentistry, University of Rochester, Rochester, NY.
  • Department of Internal Medicine, UW Health Hospitals and Clinics, Madison, WI.
  • Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.
  • Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY.

ORCID-Profile: Marissa LoCastro, Andrea Baran, Jane Liesveld, Elaine Hill, Kah Poh Loh, Jason H Mendler

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

LoCastro, M., Baran, A., Liesveld, J., Huselton, E., Hill, E., Loh, K. P., & Mendler, J. H. (2025). Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes. JCO Oncology Practice. https://doi.org/10.1200/op-24-00556

Vancouver

LoCastro M, Baran A, Liesveld J, Huselton E, Hill E, Loh KP, et al. Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes. JCO Oncology Practice. 2025. doi:10.1200/op-24-00556

BibTeX
@article{LoCastro2025,
  author = {LoCastro, Marissa and Baran, Andrea and Liesveld, Jane and Huselton, Eric and Hill, Elaine and Loh, Kah Poh and Mendler, Jason H},
  title = {Portable Medical Orders and Inpatient Cost at End of Life in Acute Myeloid Leukemia and Myelodysplastic Syndromes},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-24-00556}
}
Kostenlos starten →